What is Euro-Med Laboratories Philippines PEG Ratio?
Euro-Med Laboratories PhilippinesPHS:EURO 83 PEG Ratio is 0.81 as of Jul. 05, 2026, which is 51% below its 10-year median of 1.64. GuruFocus rates PHS:EURO with a GF Score™ of 83/100 and a GF Value™ of ₱1.02 (Fairly Valued). The stock has 7 warning signs investors should review. Among 348 Drug Manufacturers companies, Euro-Med Laboratories Philippines ranks better than 76.44% on this metric.
* The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.
PHS:EURO'
s PEG Ratio Range Over the Past 10 Years
Min: 0.6 Med: 1.64 Max: 17.94
Current: 0.81
During the past 13 years, Euro-Med Laboratories Philippines's highest PEG Ratio was 17.94. The lowest was 0.60. And the median was 1.64.
PHS:EURO's PEG Ratio is ranked better than 76.44% of 348
companies
in the Drug Manufacturers industry
Industry Median: 1.7
vs PHS:EURO: 0.81
Peter Lynch thinks a company with a P/E ratio equal to its growth rate is fairly valued.
Euro-Med Laboratories Philippines (PHS:EURO) PEG Ratio Explanation
To compare stocks with different growth rates, Peter Lynch invented a ratio called PEG Ratio. PEG Ratio is defined as the P/E ratio divided by the growth ratio. He thinks a company with a P/E ratio equal to its growth rate is fairly valued. Still he said he would rather buy a company growing 20% a year with a P/E of 20, instead of a company growing 10% a year with a P/E of 10.
Euro-Med Laboratories Philippines PEG Ratio Related Terms
Euro-Med Laboratories Philippines PEG Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Euro-Med Laboratories Philippines's PEG Ratio, along with its competitors' market caps and PEG Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Euro-Med Laboratories Philippines PEG Ratio vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Euro-Med Laboratories Philippines's PEG Ratio distribution charts can be found below:
* The bar in red indicates where Euro-Med Laboratories Philippines's PEG Ratio falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Note: The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.
Euro-Med Laboratories Philippines (PHS:EURO) has a PEG Ratio of 0.81 as of Jul. 05, 2026. Price-earnings to growth ratio is the ratio of price-earnings to a company's earnings growth rate. View historical data on Euro-Med Laboratories Philippines and its competitors. This is 51% below median its historical median of 1.64. Over the past decade, Euro-Med Laboratories Philippines' PEG Ratio has ranged from 0.60 to 17.94. According to the industry distribution chart, Euro-Med Laboratories Philippines ranks #82 out of 348 companies in the Drug Manufacturers industry, placing it in the top 23.6%.
Is Euro-Med Laboratories Philippines' PEG Ratio too high?
Euro-Med Laboratories Philippines' current PEG Ratio of 0.81 is 51% below median its 10-year median of 1.64. Over the past 10 years, this metric has ranged from a low of 0.60 to a high of 17.94. The Drug Manufacturers industry median PEG Ratio is 1.70. Euro-Med Laboratories Philippines' value of 0.81 is 52.4% below this industry median. Based on the distribution chart, Euro-Med Laboratories Philippines ranks #82 out of 348 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Euro-Med Laboratories Philippines has a GF Score™ of 83/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Euro-Med Laboratories Philippines' PEG Ratio compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Euro-Med Laboratories Philippines ranks #82 out of 348 companies for PEG Ratio. This places Euro-Med Laboratories Philippines in the top 24% of its industry — outperforming the majority of peers. The industry median PEG Ratio is 1.70. Euro-Med Laboratories Philippines' value of 0.81 is 52.4% below this benchmark. Historically, Euro-Med Laboratories Philippines' own PEG Ratio has ranged from 0.60 to 17.94 over the past decade. While the company's 10-year median is 1.64 vs. the industry median of 1.70, Euro-Med Laboratories Philippines has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PEG Ratio for a Drug Manufacturers company?
The median PEG Ratio among Drug Manufacturers companies is 1.70, based on 348 companies in the industry. Companies in the top quartile (top 25%) have a PEG Ratio significantly above this median, while those in the bottom quartile fall well below. However, PEG Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Euro-Med Laboratories Philippines's current PEG Ratio of 0.81 is 52.4% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PEG Ratio mean?
A high PEG Ratio can signal that a stock is expensive relative to its fundamentals. Price-earnings to growth ratio is the ratio of price-earnings to a company's earnings growth rate. View historical data on Euro-Med Laboratories Philippines and its competitors. For the Drug Manufacturers industry, the median PEG Ratio is 1.70 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Euro-Med Laboratories Philippines's current PEG Ratio is 0.81, which is 51% below median its own 10-year median of 1.64. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Euro-Med Laboratories Philippines stock overvalued right now?
Based on GuruFocus' analysis, Euro-Med Laboratories Philippines (PHS:EURO) is currently considered Fairly Valued. The stock's GF Value™ is ₱1.02, compared to a current price of ₱1.10 — trading 7.8% above its estimated fair value. The current PEG Ratio is 0.81, which is 51% below median its 10-year median of 1.64 and 52.4% below the Drug Manufacturers industry median of 1.70. Euro-Med Laboratories Philippines' overall GF Score™ is 83/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PEG Ratio calculated?
PEG Ratio is calculated from a company's financial statements. For Euro-Med Laboratories Philippines (PHS:EURO), the current PEG Ratio is 0.81 as of Jul. 05, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Euro-Med Laboratories Philippines (PHS:EURO) Overvalued in 2026?
Based on GuruFocus' analysis, Euro-Med Laboratories Philippines stock appears to be overvalued.
The current stock price of ₱1.10 is trading 7.8% above its estimated GF Value™ of ₱1.02.
GuruFocus considers Euro-Med Laboratories Philippines to be Fairly Valued.
Key valuation signals for PHS:EURO:
PEG Ratio: 0.81 (51% below median its 10-year median of 1.64)
GF Value™: ₱1.02 vs. price of ₱1.10 (7.8% above fair value)
Industry Position: 52.4% below the Drug Manufacturers median (#82 of 348)
No single metric tells the full story. See the PHS:EURO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Euro-Med Laboratories Philippines Business Description
Euro-Med Laboratories Philippines Inc is a pharmaceutical-based company that engages in the manufacture of pharmaceutical products such as large and small-volume parenterals and other solutions. The company also manufactures sterile water for injection, and other solutions such as ophthalmic, inhalation, irrigation, and dialysis. The Company also manufactures intravenous fluids in glass bottles, hemodialysis concentrates, ophthalmic products and disinfectants.
83GF Score
Get the complete analysis for PHS:EURO
PEG Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
PHS:EURO has been successfully added to your 
